Operator
Good day and thank you for standing by. Welcome to the Q1 2021 Editas Medicine Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]
I would now like to hand the conference over to your first speaker today, Ron Moldaver, Investor Relations. Please go ahead.
Ron Moldaver
Investor Relations
Thank you, Julian. Good morning, everyone, and welcome to our first quarter 2021 conference call. Earlier this morning, we issued a press release providing our financial results and corporate updates for the first quarter of 2021. A replay of today s call will be available on the Investors section of our website approximately 2 hours after its completion. After our prepared remarks, we will open the call for Q&A.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Editas Medicine Falls as Goldman Initiates the Stock at Sell
thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.
Author Bio
A Fool since 2019, Prosper s writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances and enjoys it just as much when they return the favor. In his free time, you ll find him curling up with a good book or doing math.
What happened
Shares of gene-editing specialist
Editas Medicine (NASDAQ:EDIT) are falling sharply on Friday and were down by 16.7% as of 2:02 p.m. EDT. The company did not report any news, but these losses are probably a result of bearish commentary from a Wall Street analyst.